Skip to main content

No Conditions

0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Labcorp
LabcorpBURLINGTON, NC
2 programs
EEG and occulometryN/A1 trial
Vitasitiq deviceN/A1 trial
Active Trials
NCT03723044Unknown80Est. May 2025
NCT03399240Completed45Est. Nov 2017
Medtronic
MedtronicNJ - Phillipsburg
1 program
Novel Non-Invasive Monitoring Parameter in Healthy VolunteersN/A1 trial
Active Trials
NCT01294514Completed27Est. Mar 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
LabcorpEEG and occulometry
LabcorpVitasitiq device
MedtronicNovel Non-Invasive Monitoring Parameter in Healthy Volunteers

Clinical Trials (3)

Total enrollment: 152 patients across 3 trials

NCT03723044LabcorpEEG and occulometry

Multistability: Perception is Inspired by Noise

Start: Jun 2020Est. completion: May 202580 patients
N/AUnknown
NCT03399240LabcorpVitasitiq device

Clinical Evaluation of the Accuracy of Vitastiq Device for Tracking Vitamin and Mineral Trend in Human Body

Start: May 2017Est. completion: Nov 201745 patients
N/ACompleted
NCT01294514MedtronicNovel Non-Invasive Monitoring Parameter in Healthy Volunteers

Novel Non-Invasive Monitoring Parameter in Healthy Volunteers

Start: Feb 2011Est. completion: Mar 201227 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.